Although Blimp1 may play an important etiologic role in development of these cancers in vivo, unfortunately, as was found with NF-κB, it cannot likely serve as a direct therapeutic target for most cancers given its essential role in directing the immune response. This evidence concerns the gene NFKB1 and cancer.